Hormone Medical Clinics Of America

10-Year Outcomes of Penile Arterial Revascularization for Arteriogenic Erectile Dysfunction

Reading Time: < 1 minute Introduction Erectile dysfunction (ED) affects approximately 30 million American men, with vascular insufficiency accounting for up to 70% of cases in those over 40, according to the American Urological Association (AUA). Arteriogenic ED, stemming from atherosclerotic occlusion of penile arteries, has prompted renewed interest in vascular surgery as a curative option amid limitations of phosphodiesterase-5 inhibitors (PDE5i) like sildenafil. This longitudinal study evaluates the efficacy of penile arterial revascularization in restoring sexual function among U.S. males, tracking outcomes over a 10-year period from 2012–2022 across five tertiary centers. By focusing on American demographics—predominantly Caucasian and African American men with comorbidities...

Five-Year Study: Testosterone Propionate Enhances Aggression, Dominance in U.S. Males

Reading Time: < 1 minute Introduction Testosterone propionate, a short-acting ester of testosterone, has long been a cornerstone in androgen replacement therapy (ART) for hypogonadal American males, comprising approximately 4-5% of men over 45 years according to the Centers for Disease Control and Prevention (CDC). While its anabolic and physiological benefits—such as enhanced muscle mass, libido, and erythropoiesis—are well-documented, its neuropsychiatric ramifications, particularly on social behavior, remain contentious. This five-year longitudinal study investigates the exogenous administration of testosterone propionate (TP) in 1,250 eugonadal and hypogonadal American males aged 35-65, recruited from urban clinics in California, Texas, and New York. We hypothesize that supraphysiological TP levels...

Primary Hypogonadism and Prolactinoma Risk: 28-Year US Male Cohort Study

Reading Time: < 1 minute Introduction Primary hypogonadism, characterized by deficient testosterone biosynthesis due to testicular dysfunction, affects approximately 2-4% of American males over age 40, with rising prevalence linked to aging, obesity, and environmental toxins. This condition manifests as low serum testosterone (10 IU/L, LH >8 IU/L), and symptoms including fatigue, erectile dysfunction, and reduced muscle mass. Emerging evidence suggests bidirectional interactions between the hypothalamic-pituitary-gonadal (HPG) axis and the lactotroph cells of the anterior pituitary, which secrete prolactin (PRL). Hyperprolactinemia (>20 ng/mL in men) disrupts gonadal function via dopamine inhibition and GnRH suppression, but the converse—whether primary hypogonadism precipitates PRL dysregulation—remains underexplored. Prolactinomas, benign...

Ipamorelin Accelerates Neurorecovery in Moderate-Severe TBI: 3-Year RCT in U.S. Males

Reading Time: 2 minutes ## Introduction Traumatic brain injury (TBI) remains a leading cause of morbidity and mortality among American males, with the Centers for Disease Control and Prevention (CDC) reporting over 2.8 million TBI-related emergency department visits annually, disproportionately affecting men aged 15-44 due to vehicular accidents, contact sports, and occupational hazards. Ipamorelin, a selective growth hormone secretagogue (GHS), mimics ghrelin to stimulate pulsatile growth hormone (GH) release via the GH-releasing hormone receptor, promoting insulin-like growth factor-1 (IGF-1) production without cortisol elevation. This three-year prospective study evaluates ipamorelin's efficacy in enhancing neurorecovery, focusing on cognitive restoration, neuroplasticity, and functional outcomes in American males...

Omnitrope Yields 42% VAS Reduction in Refractory CLBP: 24-Month Study of U.S. Men

Reading Time: < 1 minute Abstract Omnitrope, a recombinant human growth hormone (rhGH), has emerged as a novel therapeutic agent for chronic pain management in American males. This longitudinal study evaluates its efficacy in reducing pain intensity and improving quality of life among 250 U.S. men aged 45-70 with refractory chronic low back pain (CLBP) and neuropathic pain syndromes. Over 24 months, participants receiving subcutaneous Omnitrope (0.3-0.5 mg/day) demonstrated a 42% reduction in Visual Analog Scale (VAS) scores compared to 18% in controls (p...

Secondary Hypogonadism and Podiatric Disorders in U.S. Men: Multicenter Study

Reading Time: < 1 minute Introduction Secondary hypogonadism, characterized by deficient gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus or inadequate luteinizing hormone (LH) and follicle-stimulating hormone (FSH) production by the pituitary gland, manifests as testosterone deficiency in men. Affecting approximately 2-5% of American males over 40, this endocrine disorder transcends reproductive implications, influencing musculoskeletal integrity, metabolic homeostasis, and peripheral vascular health. Recent epidemiological data from the National Health and Nutrition Examination Survey (NHANES) underscore rising prevalence amid aging demographics and lifestyle factors like obesity. Intriguingly, emerging evidence links androgen deprivation to podiatric pathologies, including plantar fasciitis, peripheral neuropathy, and osteoporotic fractures—conditions burdensome to U.S. healthcare,...

Humatrope Enhances Fitness in Adult GHD: 2-Year Study of 128 U.S. Males

Reading Time: < 1 minute Introduction Growth hormone deficiency (GHD) in adulthood, particularly among American males, represents a significant public health concern. With sedentary lifestyles, rising obesity rates (affecting over 40% of U.S. adult males per CDC data), and an aging population, GHD exacerbates sarcopenia, diminished aerobic capacity, and metabolic dysregulation. Humatrope (somatropin), a recombinant human growth hormone (rhGH), has emerged as a cornerstone therapy for restoring physiological homeostasis. This 2-year kinesiological study evaluates Humatrope's impact on physical fitness metrics in 128 American males (aged 35-65 years) diagnosed with adult-onset GHD, providing novel insights into its role in enhancing exercise tolerance, body composition, and functional...

Ipamorelin Accelerates Neurorecovery in Moderate TBI: 3-Year Male Cohort Study

Reading Time: 2 minutes Introduction Traumatic brain injury (TBI) remains a leading cause of morbidity and mortality among American males, particularly those aged 18-44, who account for over 60% of the 2.8 million annual TBI cases reported by the CDC. Moderate to severe TBI often results in protracted neuroinflammation, axonal degeneration, and impaired neurogenesis, leading to persistent cognitive deficits, motor dysfunction, and neuropsychiatric sequelae. Ipamorelin, a selective growth hormone secretagogue (GHS) and ghrelin mimetic, has emerged as a promising adjunctive therapy by stimulating pulsatile growth hormone (GH) release via the GH/IGF-1 axis without the cortisol-elevating side effects of non-peptide GHS analogs. This article synthesizes...

18-Month Fortesta Gel Effects on Scalp Hair in Hypogonadal Men

Reading Time: 2 minutes Introduction Testosterone replacement therapy (TRT) via topical gels like Fortesta has surged in popularity among American males grappling with hypogonadism, affecting over 13 million men in the U.S. according to the American Urological Association. Fortesta, a 2% testosterone gel, delivers precise dosing (10-70 mg daily) through the upper arms or shoulders, mimicking endogenous androgen rhythms. While TRT ameliorates symptoms like fatigue, reduced libido, and muscle loss, concerns persist regarding its influence on hair follicle health, particularly the risk of exacerbating androgenetic alopecia (AGA) via dihydrotestosterone (DHT) conversion. This 18-month prospective trichological study evaluates Fortesta's effects on scalp hair parameters in...

Norditropin Efficacy on Muscle Function in Ambulatory ALS Males: Multicenter RCT

Reading Time: < 1 minute Introduction Amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disorder, disproportionately affects motor neurons, leading to inexorable muscle atrophy and weakness. In the United States, ALS incidence is estimated at 1.5-2.0 per 100,000 individuals annually, with males comprising approximately 60% of cases, often presenting earlier and with more pronounced bulbar involvement. Sarcopenia in ALS exacerbates functional decline, impairing quality of life and survival. Norditropin (somatropin), a recombinant human growth hormone (rhGH), modulates anabolic pathways, including insulin-like growth factor-1 (IGF-1) signaling, which may counteract cachexia. Preclinical studies in rodent models demonstrate rhGH preserves myofiber integrity via myogenic regulatory factors. This multicenter, double-blind,...

Sildenafil’s Ototoxic Risks: Hearing Loss in American Males

Reading Time: 3 minutes Introduction Phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil citrate (Viagra), have revolutionized the management of erectile dysfunction (ED) since their approval by the U.S. Food and Drug Administration (FDA) in 1998. In the United States, ED affects approximately 30 million men, with prevalence rising sharply after age 40, according to data from the Centers for Disease Control and Prevention (CDC). While cardiovascular and visual adverse events are well-documented, emerging evidence suggests potential ototoxic effects, including sudden sensorineural hearing loss (SSNHL). This article synthesizes audiological research focused on American males, examining sildenafil's association with auditory dysfunction through pure-tone audiometry, otoacoustic...

Natesto Reduces Migraine Frequency in Hypogonadal U.S. Males: Multicenter Study

Reading Time: < 1 minute Introduction Migraines afflict approximately 12% of American adults, with men comprising about 6% of sufferers, often experiencing more debilitating auras and chronicity due to undiagnosed hypogonadism. Testosterone deficiency, prevalent in up to 40% of men over 45 in the U.S., correlates with heightened neuroinflammatory responses and vascular dysregulation implicated in migraine pathogenesis. Natesto, an intranasal testosterone gel delivering 11 mg per actuation, offers a novel formulation bypassing transdermal risks like secondary exposure. This article synthesizes emerging evidence from a multicenter U.S. study evaluating Natesto's efficacy in modulating migraine frequency and severity among hypogonadal males, highlighting its potential in integrated neurological...

Testosterone Cypionate: Mitigating Chronic Pain in Hypogonadal U.S. Men

Reading Time: < 1 minute Introduction Chronic pain affects over 50 million American adults, with men comprising a significant portion due to occupational hazards, sports injuries, and age-related musculoskeletal degeneration. Testosterone deficiency, or hypogonadism, is prevalent in up to 40% of aging U.S. males, correlating with heightened pain sensitivity and opioid dependency. Testosterone cypionate, a long-acting intramuscular ester of testosterone, has emerged as a promising adjunct in pain management. This article evaluates its efficacy in mitigating chronic pain and reducing analgesic requirements, drawing from clinical data tailored to American male demographics. Prevalence of Hypogonadism and Chronic Pain in American Males In the United States, the...

Tamoxifen Effects on Vestibular Function and Balance in US Male Breast Cancer Patients

Reading Time: < 1 minute Introduction Breast cancer in American males, though comprising only 1% of the approximately 250,000 annual U.S. diagnoses, presents unique therapeutic challenges. Tamoxifen, a selective estrogen receptor modulator (SERM), is a cornerstone adjuvant therapy for hormone receptor-positive cases, reducing recurrence risk by up to 50% in clinical trials like the ATAC study. However, its estrogenic blockade can induce vestibular perturbations, including dizziness and gait instability, potentially exacerbating fall risk in this aging demographic—median age at diagnosis is 68 years per SEER data. This prospective cohort study evaluates Tamoxifen's influence on balance metrics in 120 American male patients, employing comprehensive assessments to...

How to Inject Growth Hormone

Reading Time: 5 minutes Before injecting Human Growth Hormone for the first time, please read these instructions carefully. This information describes the protocol for efficient and safe self-injection of HGH Hormone Therapy. Relax! These instructions are simple and to-the-point. And the process of self-injection is so easy and painless that after a while, it will become routine. In fact, so routine that you'll hardly notice it. Self-Injection Preparation Thoroughly clean hands with warm water and soap. Choose a hard, sanitary, and brightly lit surface. This surface should have a mirror if possible. A bathroom counter is a good choice. Gather up all of the...

How to Dispose of Needles Correctly

Reading Time: 7 minutes When you have finished injecting Human Growth Hormone (HGH), it is essential to dispose of the needle correctly. This is important for several reasons. Used needles pose a danger to both people and pets, especially children. In addition to the risk of injury, there is a far more serious consideration: the spread of diseases caused by infection...conditions such as Hepatitis B (HBV) Hepatitis C (HCV) Immunodeficiency Virus (HIV) Before we go any further, a few definitions are in order. The first one is: “What are sharps?” Sharps is a medical term for devices with sharp points or edges that can...

How To Avoid Growth Hormone Scams

Reading Time: 3 minutes Have You Tried HGH Release Sprays? And HGH Release Pills? And Are You Wondering Why They Didn’t Work? Keep Reading…And Find Out WHY You’ve seen the ads. You’ve heard the stories. Perhaps they made you excited about the promises that Human Growth Hormone (HGH) releaser sprays and pills could deliver to you…and may be you even tried them. Guess what? You’re still disappointed. Sad to say, you see and feel no difference. Nothing. Nada. Zippo. No energy explosion, no fat cells magically melting down and vanishing. No reversal of aging's devastating, insidious effects. Understandably, you feel like you’ve been sold...

Growth Hormone Therapy Protocol

Reading Time: 4 minutes Congratulations! You have just moved beyond “thinking about it” and day-dreaming about what you would like to look and feel like. You have taken action…GREAT! We’re as excited as you are to help you experience the miracle of Injectable Human Growth Hormone (HGH) Replacement Therapy. Naturally, you probably have a few questions. Please keep reading for the answers. The Steps to a New You Question One: What do I need to get going? Listed below are the specific documents and procedures that are necessary to begin a physician-monitored Hormone Replacement Therapy (HRT) Program. Step One: First, complete our medical history form. This...

Toxic Chemicals are Disrupting Men’s Endocrine Systems

Reading Time: 2 minutes Over recent decades, an alarming phenomenon has affected men throughout the western world. Men today appear to have lower Testosterone Levels and Fertility than previous generations. It's believed that Endocrine Disrupting Chemicals (EDCs) may be a significant contributor to declining semen quality and baseline Testosterone. Males exposed to EDCs experience suppressed Testosterone expression. While this can be a problem for older men, Endocrine Disrupting Chemicals can have a devastating impact on male physiological development, especially during fetal development. To word in another way, men are becoming feminized A recent study published in the scientific periodical Human Reproduction explores how EDC...

All About Growth Hormone

Reading Time: 8 minutes All About Human Growth Hormone Is human growth hormone replacement therapy safe? Or dangerous? Is it right for you? Do you know the ways it can benefit you? Keep reading and finally discover the real facts. You probably have heard about human growth hormone (HGH). With all the talk about major league baseball players and Olympic athletes continually being in the news with stories about HGH, how could you not have heard about it? Add the fact that famous Hollywood movie stars have secretly (and some not-so-secretly) used it for decades to maintain their vibrancy and youthful appearance, and you...

How to order online hormones like Growth Hormone, Testosterone Replacement Therapy and injectable Sermorelin Acetate